Cardiovascular-Renal Mortality in Hawaii
نویسندگان
چکیده
منابع مشابه
Catastrophic mortality in Hawaii: an update.
TWENTY YEARS AGO, a paper in this journal listed 112 disasters that had occurred in Hawai'i prior to 1969, each of which was responsible for the loss of five or more lives. The list included tsunamis, storms, floods, earthquakes, landslides, volcanoes, explosions, fires, marine and air disasters (including many to ships and planes traveling to or from the Islands), railroad and motor vehicle ac...
متن کاملsecuritization of mortality risks in life annuities
insurers have in the past few decades faced longevity risks - the risk that annuitants survive more than expected - and therefore need a new approach to manage this new risk. in this dissertation we survey methods that hedge longevity risks. these methods use securitization to manage risk, so using modern financial and insurance pricing models, especially wang transform and actuarial concepts, ...
15 صفحه اولRenal Dysfunction, Metabolic Syndrome and Cardiovascular Disease Mortality
Background. Renal disease is commonly described as a complication of metabolic syndrome (MetS) but some recent studies suggest that Chronic Kidney disease (CKD) may actually antecede MetS. Few studies have explored the predictive utility of co-clustering CKD with MetS for cardiovascular disease (CVD) mortality. Methods. Data from a nationally representative sample of United States adults (NHANE...
متن کاملAssociation of hyperuricemia with renal outcomes, cardiovascular disease, and mortality.
BACKGROUND AND OBJECTIVES Hyperuricemia is an independent risk factor for mortality, cardiovascular disease, and renal disease in general population. However, the relationship between hyperuricemia with clinical outcomes in CKD remains controversial. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS The study investigated the association between uric acid with all-cause mortality, cardiovascular ...
متن کاملChronic renal disease and risk of cardiovascular morbidity-mortality.
The pathogenesis of cardiovascular disease in CKD differs subtly from that of non-CKD patients. As renal function declines, the role and impact of treating classical risk factors may change and diminish. However, hypertension, hypercholesterolaemia and smoking cessation management should be optimized and may require multiple agents and approaches, particularly as CKD advances. Hypertension trea...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: American Journal of Public Health and the Nations Health
سال: 1962
ISSN: 0002-9572
DOI: 10.2105/ajph.52.9.1418